Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ulcer

• Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot Ulcer
• Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
• Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
• Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
• A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
• Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease
• A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
• Alpha Lipoic Acid in Ulcerative Colitis
• A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC)
• Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
• Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream
• A Trial for Acute Severe Ulcerative Colitis
• CP101 for the Treatment of Ulcerative Colitis
• The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer
• A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
• An Early Phase 2 Clinical Study of KSP-0243
• Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
• OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
• Combination of Diet and Oral Budesonide for Ulcerative Colitis
• Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
• Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
• Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)
• A Phase II Clinical Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
• Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
• Metoclopramide in Upper Gastrointestinal Bleed
• A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis
• A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clin
• Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds
• Role of Roflumilast in Ulcerative Colitis
• Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
• Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
• R-3750 in Patients With Mild to Moderate Ulcerative Colitis
• A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis
• A Phase 2b Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
• Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
• Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
• Stem Cells for the Treatment of Pouchitis
• Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis
• Resolution of Sickle Cell Leg Ulcers With Voxelotor
• A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
• ABTECT - Maintenance
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
• A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
• Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
• Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis
• A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission
• Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)
• Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
• A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)
• Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis
• A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
• Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
• VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
• Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
• Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
• Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
• Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients
• LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
• A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers.
• A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
• Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
• Topical Sevoflurane for Treatment of Chronic Leg Ulcers
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
• Immunonutrition for Diabetic Foot Ulcers
• Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
• Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis
• Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
• Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
• Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
• Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis
• Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis
• A Study of GM-XANTHO in Pressure Ulcer Patients
• Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
• Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
• Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
• VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
• Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances
• A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
• Treating Diabetic Foot Ulcers, Comparing Two Topical Antimicrobial Agents, Dakin´s and Prontosan
• EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
• Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
• HCQ for Non Europeans With Mild to Severe UC
• Saffron and Ulcerative Colitis
• Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
• An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
• Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
• Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis
• Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression
• Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
• Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
• Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
• Top Down Versus Step up in Pediatric Ulcerative Colitis
• A Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis
• Therapeutic Effect of Folic Acid in Healing of Oral Ulcers
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
• Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.
• Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)
• Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
• Clinical Trial Enzyme Application Targeting Venous Leg Ulcers
• Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
• A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
• MS-20 on Patients With Ulcerative Colitis(UC)
• A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis
• Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
• Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
• Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
• A Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants With Crohn's Disease or Ulcerative Colitis
• Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis
• Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
• Effect of rhGM-CSF on the Healing of Venous Leg Ulcers
• A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease
• Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid
• Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis
• Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
• Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers
• RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.
• Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
• To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
• A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
• Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis
• Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
• Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
• Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis
• A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)
• Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
• Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
• Xeljanz and Healthy Diet
• PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
• A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
• Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis
• A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis
• Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis
• Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
• Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients
• Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis
• Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis
• Intensive Glycemic Control For Diabetic Foot Ulcer Healing
• The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers
• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
• Angiographic Delivery of AD-MSC for Ulcerative Colitis
• Effects of Local Insulin on Varicose Ulcers for Wound Healing
• Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism
• Open-label Extension Study of Brazikumab in Ulcerative Colitis
• A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis
• Hydroxocobalamin Approach to Reduction of Calprotectin With Butyrate for Ulcerative Colitis Research
• A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
• SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101
• Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan
• A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
• A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis
• Application of S26E for Diabetic Foot Ulcer Healing
• A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
• A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
• Oral Omeprazole in Bleeding Peptic Ulcer
• Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis
• Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
• Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds
• Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
• TUDCA as a Therapy for Ulcerative Colitis (UC)
• PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS
• Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers
• Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis
• A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer
• Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
• Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy
• Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment
• Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis
• Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
• Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
• Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
• Antimicrobial Therapy for Ulcerative Colitis (UC)
• Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis
• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
• Low Sulfur Fecal Transplant for Ulcerative Colitis
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
• Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Patients With Ulcerative Colitis (UC)
• TITRATE (inducTIon for acuTe ulceRATivE Colitis)
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
• ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
• TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
• The Safety and Efficacy of TET Enema in the Treatment of UC
• To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
• PRF in Management of Chronic Multiple Oral Ulcers
• Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
• Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis
• GB004 in Adult Subjects With Active Ulcerative Colitis
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
• Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
• Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)
• Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
• Fecal Microbiota Transplantation for Ulcerative Colitis
• Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
• Immediate Versus Early Endovenous Ablation In Venous Ulcer
• Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
• Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
• Efficacy & Safety of TD-1473 in Ulcerative Colitis
• Intensive Versus Conventional Glycemic Control in Diabetic Foot Ulcer Healing
• Platelet Rich Plasma in Bleeding Peptic Ulcer
• The Role of Secondary Bile Acids in Intestinal Inflammation
• Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
• Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer
• A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
• EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
• Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
• Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
• A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
• Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis
• Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers
• A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
• TWB-103 for Treating Lower Limb Ulcers on Patients With DM
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
• A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
• Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients
• Clinical Evaluation and Generalized Application of "Qing-Hua-Bu" Three Dynamic Sequential Therapy of Diabetic Ulcer
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
• A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
• A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
• Preventing Diabetic Foot Ulcers Through Cleaner Feet
• Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
• A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease
• Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
• PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
• To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis
• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
• Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
• The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
• Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
• Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers
• Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
• Beta Adrenergic Antagonist for the Healing of Chronic DFU
• A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
• Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
• An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
• Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
• Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
• Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer
• Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
• Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
• Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
• The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
• Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers
• Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
• Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers
• A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy
• Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis
• Faecal Bacteriotherapy for Ulcerative Colitis
• TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
• Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis
• This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients
• ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• Dose-response Relationship Study of S42909 on Leg Ulcer Healing
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
• Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
• Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
• Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
• Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
• Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis
• A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
• GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )
• Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
• Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction
• A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
• Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
• Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
• Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2
• Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
• Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
• Riociguat in Scleroderma Associated Digital Ulcers
• Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
• Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease
• Mercaptopurine Therapy in Ulcerative Colitis
• GSK2982772 Study in Subjects With Ulcerative Colitis
• Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
• Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis
• Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
• Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
• Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
• A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
• Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
• Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• TD-1473 for Active Ulcerative Colitis (UC)
• Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC
• Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers
• Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
• Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers
• Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
• The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
• Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis
• Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
• An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
• Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
• A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)
• Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
• Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers
• Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
• Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
• Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis
• Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis
• Entyvio (Vedolizumab) Long Term Safety Study
• ENERGI-F703 for Diabetic Foot Ulcers Phase II Study
• A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
• A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
• Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
• Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
• Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
• An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
• Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
• Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
• Ketamine and Refractory Painful Care in a Palliative Unit
• Effectiveness of Cortiment® in Patients With Ulcerative Colitis
• Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI
• Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis
• Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
• Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
• Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
• Budesonide 9 mg Capsules in Active UC
• Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis
• Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot
• Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
• Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
• A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
• Stress Ulcer Prophylaxis in the Intensive Care Unit
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
• Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
• Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
• Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
• Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
• Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
• Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
• Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET
• Topical Timolol Benefit in Venous Ulcers
• Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers
• Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
• Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment
• Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers
• An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
• Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients
• Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
• Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers
• Autologous Skin Substitute for Chronic Leg/Foot Ulcers.
• Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
• Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
• Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis
• Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• Aspirin for Venous Ulcers: Randomised Trial (AVURT)
• Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
• TP0502-Pharmaco-Scintigraphic-Study and Amendment
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
• Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
• Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)
• Curcumin in Pediatric Ulcerative Colitis
• Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis
• DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
• Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
• Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients
• Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers
• A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer
• Effect of Topic Pirfenidone in Diabetic Ulcers
• Use of the Ulcerative Colitis Diet for Induction of Remission
• PRP ULCERAS: Clinical Trial Phase III
• Low Dose IL-2 for Ulcerative Colitis
• The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
• Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
• Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]
• Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
• Low Dose Aspirin for Venous Leg Ulcers
• Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
• Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
• A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
• The NOR-SWITCH Study
• Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
• A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
• EZCast-DFU Study With Portal for Application of Topical Medications
• Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
• Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
• Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
• Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
• Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
• Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis
• Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
• Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
• Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
• Effect of Local Application of Boron on Diabetic Foot Ulcers
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
• Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women
• Hyperbaric Oxygenation in Diabetic Ulcer
• Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
• Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers
• Manipulating the Microbiome in IBD by Antibiotics and FMT
• Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
• Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.
• Pressure Ulcer Healing With Microcyn
• Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.
• Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding
• A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
• Early Serum Infliximab Levels in Severe Ulcerative Colitis.
• To Assess Analgesia Provided by Continuous Sciatic Nerve Block in Patients With Hypertensive Leg Ulcer
• BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects
• A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
• MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
• Intensive Insulin Treatment and Ischemic Foot Ulcer
• Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection
• Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
• Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients
• A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
• Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
• TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
• Risk of Uncomplicated Peptic Ulcer in the General Population
• HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
• A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
• Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
• Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers
• Ulcerative Colitis and Vitamin D Supplementation
• Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
• A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
• Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
• Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
• The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
• Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers
• CSTC1 for Diabetic Foot Ulcers Phase II Study
• Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
• A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
• Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
• Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis
• Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
• High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
• TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
• A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
• Photodynamic Therapy for Ulcerative Colitis
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis
• Efficacy of Gralise® for Chronic Pelvic Pain
• Adalimumab in the Treatment of Chronic Pouchitis
• Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
• A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis
• Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
• Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects
• Vitamin D Treatment in Ulcerative Colitis
• Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
• Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
• Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care
• The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
• Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
• Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
• A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
• A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
• Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
• Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers
• A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
• Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
• Predicting Response to Standardized Pediatric Colitis Therapy
• Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)
• Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers
• Helicobacter Eradication Aspirin Trial
• Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
• Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
• The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
• A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
• Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
• Role of Healthy Bacteria in Ulcerative Colitis
• Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
• Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
• DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
• Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
• Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
• Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
• A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
• A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
• Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
• Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
• Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
• Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer
• Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis
• Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova
• Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
• Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds
• Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
• Outcomes of Non-infected Diabetic Foot Ulcers With/Without Antibiotics
• Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis
• Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
• Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
• Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
• Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
• Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
• The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs
• Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients
• Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers
• A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
• The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis
• Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
• Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
• Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
• Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
• A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
• Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
• Oral OKT3 for the Treatment of Active Ulcerative Colitis
• HP011-101, HP828-101, and Standard Care for Pressure Ulcers
• Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
• Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
• A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis
• The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
• The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
• Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
• Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
• A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
• Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
• Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
• Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
• Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis
• Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
• A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
• Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation
• Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
• A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers
• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
• Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy
• Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults
• Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
• A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
• Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers
• Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
• Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
• Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
• The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
• (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets
• Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
• Study of Cimzia for the Treatment of Ulcerative Colitis
• A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
• Basiliximab Maintenance in Ulcerative Colitis
• Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
• A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
• Cannabis for Inflammatory Bowel Disease
• Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
• Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
• Cannabidiol for Inflammatory Bowel Disease
• Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis
• Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)
• Propionyl-L-Carnitine in Ulcerative Colitis
• Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
• Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
• A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
• The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
• Mycotic Ulcer Treatment Trial I
• Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
• Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)
• Calcium Dobesilate for Chronic Venous Wounds
• Becaplermin Gel for MARTORELL's Hypertensive Leg Ulcers
• Trial of Chinese Prescription on Ulcerative Colitis
• A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
• Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
• Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers
• H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection
• Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
• Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
• Curcumin in Pediatric Inflammatory Bowel Disease
• Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
• Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration
• Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
• A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• Botulinum Toxin Effects on Plantar Ulcer Recurrence
• Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion
• Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer
• Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis
• Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
• THERMES ET VEINES: Spa for Prevention of Leg Ulcers
• Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
• Clinical Trial to Investigate Treatment With Photodynamic Therapy to Reduce Levels of Bacteria in Leg Ulcers
• Topical Nitric Oxide Trial in Chronic Non-Healing Wounds
• The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
• A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
• A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
• Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers
• (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
• Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
• Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
• An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
• Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
• Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
• A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
• Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers
• Reduction of Bacteria in MRSA Positive Ulcers
• Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
• The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)
• Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers
• A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
• Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
• Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
• Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
• Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
• Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
• Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
• Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis
• A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).
• Thalidomide in Pediatric Inflammatory Bowel Diseases.
• Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
• Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
• High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
• The Colitis Once Daily Asacol Study
• European Safety Registry in Ulcerative Colitis (P04808)
• A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
• A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
• (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
• (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
• Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
• A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers
• Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
• Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
• The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
• Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
• Dose Escalation and Remission (DEAR)
• Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
• Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
• Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
• Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
• Ulcer Prevention II
• Prevention of Gastric Ulcers
• Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
• Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
• A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis
• Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
• A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
• Canadian Active & Maintenance Modified Pentasa Study
• Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
• Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec
• Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
• Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
• Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
• Ulcer Prevention Study in Post Gastric Bypass Patients
• Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
• Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476
• Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
• MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
• Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
• Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)
• Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen
• Cost-effectiveness of TPMT Pharmacogenetics
• Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
• A Comparison of Once a Day Dose Compared to 2 Doses/Day
• Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
• Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
• Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
• Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis
• An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
• GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
• Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers
• OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
• Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
• Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
• Basiliximab in Moderate to Severe Ulcerative Colitis
• FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
• Open-Label Adalimumab for Ulcerative Colitis Patients
• A Study of Abatacept in Patients With Active Ulcerative Colitis
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
• Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer
• Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
• Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers
• TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers
• A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
• Study of Thymosin Beta 4 in Patients With Pressure Ulcers
• High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
• Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib
• An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
• Antibiotics for the Treatment of Ulcerative Colitis
• A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
• Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients
• Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
• Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission
• Steroids for Corneal Ulcers Trial
• Bosentan in Digital Ulcers
• Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
• Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
• Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
• Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
• Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis
• Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
• Therapeutic Study of ONO-4819CD for Ulcerative Colitis
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
• Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
• Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
• Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous)
• Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
• A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
• Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
• Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
• Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
• Rituximab in Active Ulcerative Colitis
• Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
• Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis
• Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis
• A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
• Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer
• Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
• Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
• Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
• Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
• Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride
• Lansoprazole Preventing Gastroduodenal Stress Ulcerations
• Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
• A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
• Asacol Dosing Study for Active Ulcerative Colitis
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin
• The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
• A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
• Episodic Acyclovir Therapy for Genital Ulcers
• Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
• The Application of Fibrin Glue in Ocular Surface Diseases
• Effect of Selective COX-2 Inhibition on Ulcer Healing
• Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
• Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding
• Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
• Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
• Improving Diabetic Foot Ulcers With Atorvastatin
• Helicobacter Pylori Eradication With a New Sequential Treatment
• A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
• Oxandrolone to Heal Pressure Ulcers
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis
• CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
• Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
• A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
• A Trial of Rosiglitazone for Ulcerative Colitis
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
• ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.
• ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis
• Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
• Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
• Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
• Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
• A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
• Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis
• Research Study in Patients With Severe Ulcerative Colitis
• Morphine Gel for Bedsores
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
• Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
• Preliminary Testing of New Treatment for Chronic Leg Wounds